NL PHYSIO (1008.736.751): annual accounts, directors and company register

NL PHYSIO

Marche-en-Famenne ·KBO/BCE: BE 1008.736.751

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	0.9%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.8%
9	3.0%	3.1%
10	5.6%	6.2%

Line	2025	2024
Balance sheet: assets
Total assets`20/58`	124,619	50,417
Fixed assets`21/28`	2,017	3,560
Tangible fixed assets`22/27`	2,017	3,560
Furniture and vehicles`24`	2,017	3,560
Current assets`29/58`	122,602	46,857
Amounts receivable within one year`40/41`	363	363
Other amounts receivable`41`	363	363
Cash at bank and in hand`54/58`	121,977	46,357
Deferred charges and accrued income`490/1`	262	137
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	124,619	50,417
Equity`10/15`	119,297	49,039
Contributions`10/11`	500	500
Profit (loss) carried forward`14`	118,797	48,539
Amounts payable`17/49`	5,323	1,378
Amounts payable within one year`42/48`	5,323	1,378
Trade debts`44`	-	66
Suppliers`440/4`	-	66
Taxes, remuneration and social security`45`	4,231	300
Taxes`450/3`	4,231	300
Other amounts payable`47/48`	1,091	1,012
Income statement
Gross operating margin`9900`	93,062	64,906
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	2,636	1,945
Other operating charges`640/8`	312	-
Operating profit (loss)`9901`	90,114	62,960
Financial charges`65/66B`	32	-
Recurring financial charges`65`	32	-
Profit (loss) for the period before taxes`9903`	90,082	62,960
Income taxes`67/77`	18,991	13,563
Profit (loss) for the period`9904`	71,091	49,398
Profit (loss) for the period to be appropriated`9905`	71,091	49,398
Appropriation of the result
Profit (loss) to be appropriated`9906`	119,630	49,398
Profit (loss) brought forward from the previous period`14P`	48,539	-
Profit to be distributed`694/7`	833	859
Return on contributions (dividend)`694`	833	859
Document	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	21-05-2026	2026-00116672	PDF
31-12-2024	micro format	06-06-2025	2025-00133127	PDF

Line	2025	2024
EBITDA	92,750	64,906
Cash flow	73,727	51,343
Investment in fixed assets	1,405	5,506
Change in cash	75,620	-
Working capital	117,279	45,478
Solvency	95.7%	97.3%
Current ratio	23.03	33.99
Debt to equity	0.04	0.03
ROE	59.6%	100.7%
ROA	57.0%	98.0%
Interest coverage	over 100	-

Item	2025	2024
Tangible fixed assets	€1,405	€5,506
Depreciation and write-downs of the year	€2,636	€1,945

Overview

Lifetime

Key points

Equity

Turnover

Liquidity

Checked score

Score breakdown

Comparable companies, two years later

Credit verdict

Signals

Board and ownership

Recent changes

Official details

Annual accounts 2025

Insights on NL PHYSIO

Financials

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on NL PHYSIO

Board & ownership

Board

Mandates through the years

Control

Capital

Articles of association

Founder

Network & group

No group

Timeline

Timeline

History

Company details

Identity

Activities

Registered office and establishments

Buildings and parcels at the address

Location

Parcels